Amphastar Pharmaceuticals, Inc. (AMPH)

NASDAQ: AMPH · Real-Time Price · USD

19.83

-1.18 (-5.62%)

At close: Mar 3, 2026, 4:00 PM EST

20.34

+0.51 (2.57%)

After-hours: Mar 3, 2026, 7:01 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceutical Products	719.89M	731.97M	644.40M	498.99M	419.57M
Pharmaceutical Products Growth	-1.65%	13.59%	29.14%	18.93%	26.62%
Active Pharmaceutical Ingredients (API)	-	-	-	-	18.20M
Active Pharmaceutical Ingredients (API) Growth	-	-	-	-	-1.52%
Total	719.89M	731.97M	644.40M	498.99M	437.77M
Total Growth	-1.65%	13.59%	29.14%	13.98%	25.13%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	681.42M	707.68M	635.19M	486.83M	419.87M
United States Growth	-3.71%	11.41%	30.47%	15.95%	26.05%
China	3.18M	4.34M	4.51M	4.70M	6.02M
China Growth	-26.62%	-3.68%	-4.09%	-21.98%	90.45%
France	35.28M	19.95M	4.70M	7.46M	11.88M
France Growth	76.87%	324.58%	-37.00%	-37.23%	-12.60%
Total	719.89M	731.97M	644.40M	498.99M	437.77M
Total Growth	-1.65%	13.59%	29.14%	13.98%	25.13%

Source: S&P Global Market Intelligence.